On June 28th, local time in the United States, the Center for Tobacco Products of the FDA updated the information on tobacco compliance inspection results on the FDA website. The newly named "Tobacco Compliance Inspection Results Database" integrates all tobacco retail inspection results and aims to provide convenience for the public, public health organizations, and the tobacco industry.
The new database also enhances the ability to search for regulatory compliance and enforcement action results for both brick-and-mortar and online retailers, including warning letters, civil fines, and instructions to cease tobacco sales. Previously, this information was spread across various locations on the FDA website, but this upgrade will make it easier for visitors to find FDA compliance and enforcement actions against retailers in one centralized location.
In addition, this centralized database will be updated monthly with the latest compliance check results.
The database website is: https://timp-ccid.fda.gov/
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
